Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Patterns of primary antiretroviral drug resistance in antiretroviral-naive HIV-1-infected individuals in a midwest university clinic.

Literature DB >> 17053358

Patterns of primary antiretroviral drug resistance in antiretroviral-naive HIV-1-infected individuals in a midwest university clinic.

Jessica R Grubb¹, Ekachai Singhatiraj, Kristin Mondy, William G Powderly, Edgar T Overton.

Abstract

A total of 192 HIV-1-infected antiretroviral-naive individuals had genotyping performed in our midwest university clinic between 2003 and 2005. The overall prevalence of resistance with either a reverse transcriptase or major protease mutation was 18%. There did not seem to be a significant difference in primary resistance patterns between different modes of HIV transmission (heterosexual versus men who have sex with men), gender or between white and African-American individuals.

Entities: Disease Species

Mesh：

Substances：

Year: 2006 PMID： 17053358 DOI： 10.1097/01.aids.0000247579.08449.b6

Source DB: PubMed Journal: AIDS ISSN： 0269-9370 Impact factor: 4.177

Keyword Cloud
Cited

10 in total

Review 1. Burden of nonnucleoside reverse transcriptase inhibitor resistance in HIV-1-infected patients: a systematic review and meta-analysis.

Authors: Sonya J Snedecor; Lavanya Sudharshan; Katherine Nedrow; Abhijeet Bhanegaonkar; Kit N Simpson; Seema Haider; Richard Chambers; Charles Craig; Jennifer Stephens
Journal: AIDS Res Hum Retroviruses Date: 2014-07-08 Impact factor: 2.205

2. Detection of human immunodeficiency virus (HIV) type 1 M184V and K103N minority variants in patients with primary HIV infection.

Authors: Thomas A Toni; Eugene L Asahchop; Daniela Moisi; Michel Ntemgwa; Maureen Oliveira; Bernard Masquelier; Bluma G Brenner; Mark A Wainberg
Journal: Antimicrob Agents Chemother Date: 2009-01-26 Impact factor: 5.191

3. Extreme multidrug resistant HIV-1 protease with 20 mutations is resistant to novel protease inhibitors with P1'-pyrrolidinone or P2-tris-tetrahydrofuran.

Authors: Johnson Agniswamy; Chen-Hsiang Shen; Yuan-Fang Wang; Arun K Ghosh; Kalapala Venkateswara Rao; Chun-Xiao Xu; Jane M Sayer; John M Louis; Irene T Weber
Journal: J Med Chem Date: 2013-05-01 Impact factor: 7.446

4. Prevalence of drug resistance and associated mutations in a population of Hiv-1+ Puerto Ricans in 2005.

Authors: Luis A Cubano; Luz Cumba; Lycely C del Sepúlveda-Torres; Nawal Boukli; Eddy Ríos-Olivares
Journal: Bol Asoc Med P R Date: 2010 Jul-Sep

5. Gender differences in discontinuation of antiretroviral treatment regimens.

Authors: Mirjam-Colette Kempf; Maria Pisu; Anastasiya Dumcheva; Andrew O Westfall; J Michael Kilby; Michael S Saag
Journal: J Acquir Immune Defic Syndr Date: 2009-11-01 Impact factor: 3.731

6. Both human immunodeficiency virus cellular DNA sequencing and plasma RNA sequencing are useful for detection of drug resistance mutations in blood samples from antiretroviral-drug-naive patients.

Authors: Saverio G Parisi; Caterina Boldrin; Mario Cruciani; Giangiacomo Nicolini; Isabella Cerbaro; Vinicio Manfrin; Federico Dal Bello; Elisa Franchin; Marzia Franzetti; Maria C Rossi; Anna M Cattelan; Laura Romano; Maurizio Zazzi; Massimo Andreoni; Giorgio Palù
Journal: J Clin Microbiol Date: 2007-04-18 Impact factor: 5.948

Patterns of primary antiretroviral drug resistance in antiretroviral-naive HIV-1-infected individuals in a midwest university clinic.

Review 1. Burden of nonnucleoside reverse transcriptase inhibitor resistance in HIV-1-infected patients: a systematic review and meta-analysis.

2. Detection of human immunodeficiency virus (HIV) type 1 M184V and K103N minority variants in patients with primary HIV infection.

3. Extreme multidrug resistant HIV-1 protease with 20 mutations is resistant to novel protease inhibitors with P1'-pyrrolidinone or P2-tris-tetrahydrofuran.

4. Prevalence of drug resistance and associated mutations in a population of Hiv-1+ Puerto Ricans in 2005.

5. Gender differences in discontinuation of antiretroviral treatment regimens.

6. Both human immunodeficiency virus cellular DNA sequencing and plasma RNA sequencing are useful for detection of drug resistance mutations in blood samples from antiretroviral-drug-naive patients.

Review 7. The essentials of HIV: a review for nurses.

8. Resting cerebral blood flow: a potential biomarker of the effects of HIV in the brain.

9. Prevalence of Drug Resistance and Associated Mutations in a Population of HIV-1(+) Puerto Ricans: 2006-2010.

10. Prevalence and trends in transmitted and acquired antiretroviral drug resistance, Washington, DC, 1999-2014.